X0306 4 2022-01-31 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856069 Doyle Ramona C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 0 1 0 0 Chief Medical Officer Class A Common Stock 2022-01-31 4 M 0 15625 2.48 A 57335 D Stock Option (Right to Buy) 2.48 2022-01-31 4 M 0 15625 0.00 D 2030-12-30 Class A Common Stock 15625 694053 D Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person. Includes 1,388 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021 Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. /s/ Nathan Hatfield, attorney-in-fact 2022-02-02